Concepedia

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β<sub>2</sub>-agonist use in asthma

Claudia Cabrera, Cassandra Nan, N Lindarck, Maarten Beekman, Sofie Arnetorp, Ralf J.P. van der Valk

European Respiratory Journal · 2019 · 64 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

<b>As SABA overuse is associated with exacerbations and mortality, GINA no longer recommends SABA only as a preferred reliever in asthma. A consistent pattern of high SABA use from the SABINA programme would indicate a global public health issue.</b>http://bit.ly/33XDrlb

References

8

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +10

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman et al. · New England Journal of Medicine · 2018 · 637 citations · Full text

, , +16

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

Eric D. Bateman, Helen K. Reddel, Paul M. O’Byrne et al. · New England Journal of Medicine · 2018 · 515 citations · Full text

, , +14

GINA 2019: a fundamental change in asthma management

Helen K. Reddel, J. Mark FitzGerald, Eric D. Bateman et al. · European Respiratory Journal · 2019 · 386 citations

, , +17

The impact of inappropriate use of short acting beta agonists in asthma

J. Mark FitzGerald, Hamid Tavakoli, Larry D. Lynd et al. · Respiratory Medicine · 2017 · 96 citations · Full text

, , +12